We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock
SURF

Delisted

SURF was delisted on the 7th of September, 2023.

Back to rankings

44 hedge funds and large institutions have $145M invested in Surface Oncology, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

443% more capital invested

Capital invested by funds: $26.8M → $145M (+$119M)

250% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 6

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

52% more funds holding

Funds holding: 29 → 44 (+15)

Holders
44
Holders Change
+15
Holders Change %
+51.72%
% of All Funds
0.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
21
Increased
11
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
+$14M
2
EC
EcoR1 Capital
California
+$13.6M
3
APM
Avidity Partners Management
Texas
+$5.34M
4
BI
BVF Inc
California
+$3.81M
5
GTC
Ghost Tree Capital
New York
+$2.53M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$6.2M
2
Victory Capital Management
Victory Capital Management
Texas
-$2.69M
3
Fidelity International
Fidelity International
Bermuda
-$1.21M
4
Millennium Management
Millennium Management
New York
-$759K
5
Citadel Advisors
Citadel Advisors
Florida
-$528K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$33M +$13.6M +3,759,398 +295%
AVAI
2
Atlas Venture Associates IX
Massachusetts
$30.5M – – –
VA
3
VR Adviser
New York
$25.4M +$14M +3,877,895 New
BI
4
BVF Inc
California
$13.4M +$3.81M +1,055,477 +107%
APM
5
Avidity Partners Management
Texas
$9.7M +$5.34M +1,478,699 New
GTC
6
Ghost Tree Capital
New York
$4.59M +$2.53M +700,000 New
Victory Capital Management
7
Victory Capital Management
Texas
$3.95M -$2.69M -745,690 -55%
Renaissance Technologies
8
Renaissance Technologies
New York
$3.67M +$1.42M +393,995 +238%
SCM
9
Suvretta Capital Management
New York
$3.13M +$1.72M +476,879 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.1M – – –
Two Sigma Investments
11
Two Sigma Investments
New York
$2.57M +$1.41M +391,770 New
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$1.62M +$409K +113,280 +85%
BlackRock
13
BlackRock
New York
$1.51M +$74K +20,497 +10%
ACP
14
Acuta Capital Partners
California
$1.48M +$812K +225,000 New
BCM
15
Bridgeway Capital Management
Texas
$1.06M +$231K +64,000 +65%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$904K -$489K -135,585 -50%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$861K +$474K +131,300 New
PHP
18
Parkman Healthcare Partners
Connecticut
$820K +$451K +125,000 New
MWNA
19
Marshall Wace North America
New York
$673K +$370K +102,565 New
Squarepoint
20
Squarepoint
New York
$568K +$262K +72,657 +519%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$541K +$16.5K +4,565 +6%
SSA
22
Schonfeld Strategic Advisors
New York
$476K +$262K +72,600 New
Millennium Management
23
Millennium Management
New York
$434K -$759K -210,182 -76%
Goldman Sachs
24
Goldman Sachs
New York
$173K +$54.5K +15,091 +133%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$161K – – –
1
2

SURF Hedge Fund Activity: Q2 2020 in Review

44 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q2 2020, worth a combined $145M — up 443% from $26.8M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SURF positions and 6 closed out — a net gain of 15 holders — while 11 added to existing stakes and 5 trimmed.

The largest buyer was VR Adviser, opening a new position worth an estimated $14M. The largest seller was NEA Management Company, exiting entirely with an estimated $6.2M sold.

  • 44 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q2 2020, up from 29 in Q1 2020.
  • Funds reported $145M of Surface Oncology, Inc. Common Stock stock for Q2 2020, up 443% quarter-over-quarter.
  • 21 funds opened new Surface Oncology, Inc. Common Stock positions in Q2 2020 and 6 closed out, a net change of +15 holders.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q2 2020 was VR Adviser, an estimated $14M added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q2 2020 was NEA Management Company, an estimated $6.2M sold.

Based on aggregated 13F filings for Q2 2020.